Pathology CPT Code Changes 2026: Billing, Documentation & Compliance
February 4, 2026

The 2026 pathology CPT code changes include 7 new codes, 2 revised codes, and 2 deleted codes affecting clinical laboratory billing and reimbursement. These updates from the American Medical Association (AMA) impact infectious disease testing, cytogenomic analysis, oncology diagnostics, and antimicrobial susceptibility studies, effective January 1, 2026.
The AMA released 288 new CPT codes, 84 deleted codes, and 46 revised codes across all specialties for 2026. Healthcare providers must update billing systems, train staff, and modify documentation practices to maintain compliance and accurate reimbursement.
New pathology codes include:
The AMA added these codes to reflect advances in genetic testing, infectious disease diagnostics, and antimicrobial resistance detection.
81354 covers cytogenomic analysis for constitutional chromosomal abnormalities using optical genome mapping (OGM). This code interrogates structural and copy number variants through genome-wide analysis.
The code applies to:
81524 covers oncology testing for central nervous system tumors through DNA methylation analysis of 10,000 or more methylation sites. This code utilizes DNA extracted from formalin-fixed tumor tissue and reports the probability of matching reference tumor families.
Key reporting elements include:
87182 detects carbapenemase enzymes, including KPC, NDM, and VIM, via a multiplex immunoassay. This qualitative test identifies antibiotic resistance mechanisms per isolate.
87183 identifies carbapenem resistance genes, including blaKPC, blaNDM, blaVIM, blaOXA-48, and blaIMP using the amplified probe technique. This molecular test detects genetic markers of antibiotic resistance per isolate.
Both codes address:
87494 covers infectious agent detection for Chlamydia trachomatis and Neisseria gonorrhoeae using the multiplex amplified probe technique. This code combines both pathogens in a single test.
87627 detects joint-space pathogens and drug-resistance genes using a multiplexed probe-based amplification technique, testing 26 or more targets. This comprehensive panel simultaneously identifies multiple infectious agents and antimicrobial resistance markers.
87812 covers infectious agent antigen detection for SARS-CoV-2 and influenza virus types A and B using an immunoassay with direct optical observation. This point-of-care test provides visual interpretation for three viral pathogens.
Revised codes 83015 and 83018 update heavy metal testing descriptors to include additional analytes like gadolinium. The modifications expand the list of detectable heavy metals and clarify the distinction between quantitative and qualitative testing.
83015 now covers qualitative heavy metal testing for antimony, arsenic, barium, beryllium, bismuth, gadolinium, and mercury. This code enables testing for any number of analytes in qualitative mode.
83018 provides quantitative heavy metal testing for antimony, arsenic, barium, beryllium, bismuth, gadolinium, and mercury. This code bills per analyte for metals not elsewhere specified.
The revision adds:
Deleted codes 0450U and 0451U for multiple myeloma liquid chromatography with tandem mass spectrometry testing are no longer valid after December 31, 2025. Healthcare organizations must identify alternative codes for these services.
0450U covered oncology testing for multiple myeloma using LC-MS/MS for monoclonal paraprotein sequencing analysis. This baseline test reported the presence or absence of detectable clonotypic peptides in serum.
0451U covered oncology testing for multiple myeloma using LC-MS/MS for peptide ion quantification. This test compared results with the baseline to determine monoclonal paraprotein abundance.
Revised codes 83015 and 83018 expand heavy metal testing to include gadolinium and clarify billing for multiple analytes. The updates address increased demand for gadolinium testing related to MRI contrast exposure.
Code 83015 allows billing for the qualitative detection of any number of heavy metals in a single specimen. This code does not bill per analyte but covers the entire qualitative panel.
Use code 83015 when:
Code 83018 bills per analyte for quantitative heavy metal measurement. This code requires specific concentration reporting for each metal tested.
Use code 83018 when:
Common errors include using deleted codes after December 31, 2025, billing 87182 and 87183 together for the same isolate, and reporting 81524 without meeting the 10,000 methylation site threshold. These mistakes result in claim denials and payment delays.
The 2026 pathology and laboratory CPT code changes require laboratories to implement 7 new codes, update 2 revised codes, and discontinue 2 deleted codes by January 1, 2026. These updates expand testing capabilities for
Healthcare organizations need to update their billing systems to ensure accurate coding. Laboratories should refer to the AMA CPT 2026 codebook for complete implementation guidance. Oregon Billing Service provides comprehensive support for laboratories transitioning to new coding requirements. Contact us now!
There are a total of 270 new codes, 420 overall updates in the CPT 2025 code set, including 270 new codes, 112 deletions, and 38 revisions.
For 2026, the update includes 487 new diagnosis codes, 38 R-code revisions, and 28 invalidated or deleted codes.
Key updates in the CPT 2026 code set include new codes for digital health services such as remote patient monitoring, medical services involving hearing devices and augmented intelligence (AI), and a comprehensive update to codes for leg revascularization.